FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome
Madeline Niederkorn(International Society for Experimental Hematology), John D. Crispino(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
|Journal of Clinical Investigation|2021|88
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
|The Journal of Experimental Medicine|2015|84
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia
|Leukemia|2021|60
Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis
|Blood|2019|50
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
|Blood Cancer Journal|2020|33